Progyny, Inc. Common Stock (PGNY) Stock Price

PGNYStock
$26.86+25.93%52W
Market Cap$2.06B
P/E35.22x
PEG Ratio3.97
Div yield—
Beta0.98

PGNY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)46.53%
Price vs S&P 500 (4W)1.33%
PEG Ratio3.97
VGM Score57.97
P/E Ratio (Annual)35.22x

PGNY Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026$0.52$0.55+6.16%(+$0.03)
Q1 2026$0.44$0.50+14.72%(+$0.06)
Q4 2025$0.40$0.48+19.93%(+$0.08)
Q3 2025$0.39$0.45+15.38%(+$0.06)
Q2 2025$0.43$0.48+12.06%(+$0.05)

PGNY Analyst Recommendations

Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.24
4.24
4.18
4.17

Industry Peers — Health Services(17)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/E Ratio (Annual)Revenue Growth TTM (YoY)Operating Margin (TTM)ROE (TTM)Price
PGNYProgyny, Inc. Common Stock
CBC35.2x5.5%8.6%16.0%$26.86
DVADaVita Inc.BCB16.0x6.5%15.1%181.2%$187.31
FMSFresenius Medical Care AGADC10.7x-0.5%9.4%7.2%$22.17
SHCSotera Health Company Common StockDBC65.5x8.2%32.6%26.8%$17.89
AGLagilon health, inc.BBB—0.3%-5.2%-110.3%$85.12
MCTACharming Medical Limited Class A Ordinary SharesFFA371.6x—15.4%—$29.36
VMDViemed Healthcare, Inc. Common SharesBCC24.2x25.2%7.5%10.3%$9.48
PARKPark Dental Partners, Inc. Common StockBFC17.9x—-2.8%-18.3%$18.95
CCELCryo-Cell International Inc.CDB69.5x-2.0%0.6%38.2%$4.42
MGRXMangoceuticals, Inc. Common StockDFF—-38.9%-4761.2%-106.1%$0.29
BRTXBioRestorative Therapies, Inc. Common Stock (NV)—DF—-8.5%-3975.0%-423.8%$1.54

About Progyny, Inc. Common Stock

Progyny provides fertility, family building, and women's health benefits management solutions to employers. The company operates an integrated platform called Smart Cycles that combines treatment services, access to a curated network of high-quality fertility specialists, and active management of a selective provider network to deliver comprehensive reproductive health benefits.